Sign in

CIK 0001651308 · Large accelerated filer

BeOne Medicines Ltd.

Sign in to watch
Ticker
BEIGF
Exchange
Nasdaq, OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
operating
EIN
981209416
Phone
41-616851900
Business address
C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, Switzerland, 4051
Former names
BeiGene, Ltd.

Securities

  • ONC American Depositary Shares Nasdaq
  • BEIGF Common stock OTC
  1. 4 Grant or award Director acquired 12,922 shares (grant or award)
  2. 4 Grant or award Director acquired 12,922 shares (grant or award)
  3. 4 Grant or award Director acquired 12,922 shares (grant or award)
  4. 4 Grant or award SVP, General Counsel acquired 65,585 shares (grant or award)
  5. 4 Open-market sale Global Head of R&D sold 1,325 shares at $192.42 ($254,955)
  6. 4 Open-market sale Chief Financial Officer sold 190 shares at $192.54 ($36,583)
  7. 4 Open-market sale President, COO & GM China sold 1,753 shares at $192.44 ($337,356)
  8. 4 Grant or award Director acquired 86,216 shares (grant or award)
  9. 4 Grant or award Chief Executive Officer acquired 355,641 shares (grant or award)
  10. 3 Insider Initial Statement of Ownership
  11. 4 Grant or award Director acquired 51,688 shares (grant or award)
  12. 4 Grant or award Director acquired 12,922 shares (grant or award)
  13. 144 Insider Sale of Securities
  14. 144 Insider Sale of Securities
  15. 144 Insider Sale of Securities
  16. 4 Open-market sale 10% owner sold 1,198,128 shares at an average $188.88 ($226,306,339)
  17. 8-K Event Shareholder rights changed · Bylaws or fiscal year change · Shareholder vote results · Other events
  18. 4 Open-market sale 10% owner sold 2,956,689 shares at an average $201.98 ($597,183,858)
  19. 144 Insider Sale of Securities
  20. 4 Open-market sale Global Head of R&D sold 462 shares at an average $224.74 ($103,828)

Page 25 of 64 · 1,278 filings